Functional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary study

BACKGROUND AND OBJECTIVE: People with amnestic mild cognitive impairment (aMCI) are at a higher risk of developing Alzheimers Dementia (AD) than their cognitively normal peers. Decreased glucose metabolism with F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) is a downstream marker o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Madhavi, Tripathi, Manjari, Sharma, Rajnish, Jaimini, Abhinav, MD’Souza, Maria, Saw, Sanjiv, Mondal, Anupam, Kushwaha, Suman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822410/
https://www.ncbi.nlm.nih.gov/pubmed/24250019
http://dx.doi.org/10.4103/0972-3919.119538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822410/
https://www.ncbi.nlm.nih.gov/pubmed/24250019
http://dx.doi.org/10.4103/0972-3919.119538

Ejemplares similares